To evaluate programming modalities at various targets for focal foot, knee pain, and groin pain relief.

Key Inclusion Criteria:

• Average unilateral foot, or knee or groin pain intensity of 6 or greater on a 0-10 numerical rating scale at Baseline Visit based on 7-day average NRS score
• Subject signed a valid, EC-approved informed consent form (ICF)
• Willing and able to comply with all protocol-required procedures and assessments/evaluations
• 18 years of age or older when written informed consent is obtained

Key Exclusion Criteria:

• Significant cognitive impairment at Screening that, in the opinion of the Investigator, would reasonably be expected to impair the study candidates to participate in the study
• Participating (or intends to participate) in another drug or device clinical trial that may influence the data that will be collected for this study

Adverse events were collected and reported up to end of crossover phase (approximately 18 weeks)